Laird Norton Wetherby Wealth Management’s Insmed INSM Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$204K	Buy	+1,417	New	+$174K	0.01%	884

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's INSM Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management opened a new position in Insmed (INSM) in Q3 2025: 1,417 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #884 among its holdings.

566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

Laird Norton Wetherby Wealth Management held 1,417 shares of Insmed worth $204K as of Q3 2025.
Insmed was a new Laird Norton Wetherby Wealth Management position in Q3 2025.
Insmed made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #884 holding.
566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.